Molecule Structure

Scientific Name

Digoxin

Description of the Drug

Digoxin is a cardiac glycoside used in the treatment of mild to moderate heart failure and for ventricular response rate control in chronic atrial fibrillation.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB00390

Brand Name(s)

Digamex, Digoxin, Digoxin pediatric, Lanoxicaps, Lanoxin, Lanoxin-125, Lanoxin pediatric, Lanoxin-pg, Vanoxin

Company Owner(s)

Vistapharm Inc, Mylan Pharmaceuticals Inc, Covis Pharma Gmbh, Wyeth Ayerst Laboratories, Hikma Pharmaceuticals International Ltd, Impax Laboratories Inc, Abraxis Pharmaceutical Products, Sandoz Inc, Sun Pharmaceutical Industries Inc, West-Ward Pharmaceuticals International Ltd

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Sodium/potassium-transporting ATPase PROTEIN COMPLEX GROUP INHIBITOR CHEMBL2095186

Clinical Trial(s)

Unichem Links

SureChEMBL SCHEMBL20506
Human Metabolome Database HMDB0001917
DrugBank DB00390
PubChem: Thomson Pharma 14840467 16531631
PubChem 2724385
Mcule MCULE-8165628529
LINCS LSM-2511
Nikkaji J4.082G
PDBe DGX
BindingDB 46355
EPA CompTox Dashboard DTXSID5022934
LipidMaps LMST01120023
DrugCentral 882
Metabolights MTBLC4551
Brenda 9930 229384 61332 229385 5369
Guide to Pharmacology 4725 4726
GSRS 45095b8b-e37d-43fb-b4a1-59deac2175d0
rxnorm LANOXIN DIGOXIN
PubChem: Drugs of the Future 125299298
KEGG Ligand C06956
ChEBI 4551
ZINC ZINC000242548690